Skip to main content
main-content

Insulin

News

03-07-2020 | Physical activity | News

Fructose boost may alleviate type 1 diabetes exercise-induced hypoglycemia risk

Consuming a single shot of fructose prior to exercise is a feasible strategy to reduce the risk for exercise-induced hypoglycemia among men with type 1 diabetes treated with insulin degludec, suggest findings from a proof-of-concept study.

17-06-2020 | ADA 2020 | Conference coverage | News

​​​​​​​Support for insulin degludec use in type 1 diabetes patients prone to nocturnal hypoglycemia

Findings from the HypoDeg trial suggest that insulin degludec is associated with a lower risk for hypoglycemia than insulin glargine U100 among people with type 1 diabetes who are prone to nocturnal severe hypoglycemia.

16-06-2020 | ADA 2020 | Conference coverage | News

First weekly insulin shows equivalence with glargine in type 2 diabetes

A novel insulin that can be given as a once-weekly injection has achieved promising results in a randomized phase 2 trial involving people with type 2 diabetes.

Read more

Opinion

17-12-2019 | Insulin | Editorial | Article

How can we optimize titration with new basal insulins?

Nurse and Diabetes Educator Lori Berard highlights the advantages of “concentrated” insulins and outlines her recommendations for getting titration right for patients.

30-05-2018 | Insulin | Editorial | Article

Hit early, hit hard: The EADSG insulin guidelines

Sanjay Kalra and Silver Bahendeka, East Africa Diabetes Study Group Chair, provide an overview of the latest insulin guidance developed to aid management in a challenging region, facing familiar struggles.

16-05-2018 | Devices and technology | Editorial | Article

Digital diabetology

Editorial Board member Sanjay Kalra presents his view on the march toward greater integration of digital health technologies and how traditional approaches to diabetes management are already changing.

In depth

19-02-2019 | Artificial pancreas systems | Feature | Article

What’s all the fuss about the DIY artificial pancreas?

DIY closed-loop insulin delivery has provoked controversy within the diabetes community, raising questions around patient empowerment, safety and liability, and whether the regulatory process remains fit for purpose in a technological age. medwireNews takes a look at the issues.

30-09-2018 | UKPDS | Feature | Article

The UKPDS: A lasting legacy

Twenty years after the publication of the primary findings, medwireNews talks to longtime UKPDS investigator Professor David Matthews (University of Oxford, UK) about the struggles of the team to bring the trial to completion and the impact of the findings on diabetes care.

Journal articles and book chapters

03-11-2018 | Premixed insulins | Review | Article

Expert opinion: Patient selection for premixed insulin formulations in diabetes care

Kalra S et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0521-2

04-10-2018 | Mobile technology | Review | Article

App-based insulin calculators: Current and future state

Eiland L et al. Curr Diab Rep 2018; 18: 123. doi: 10.1007/s11892-018-1097-y

18-08-2018 | Continuous glucose monitoring | Review | Article

Prevention and management of severe hypoglycemia and hypoglycemia unawareness: Incorporating sensor technology

Lucidi P et al. Curr Diab Rep 2018; 18: 83. doi: 10.1007/s11892-018-1065-6

In practice

01-06-2017 | Type 2 diabetes | Review | Article

Practical recommendations for transitioning patients with type 2 diabetes from hospital to home

Donihi AC. Curr Diab Rep 2017; 17: 52. doi: 10.1007/s11892-017-0876-1

Case reports

Image Credits